DSIP (Delta Sleep-Inducing Peptide) is a structurally short neuropeptide of natural origin that influences a number of endocrine as well as physiological processes in the central nervous system
Seven drugs have currently been approved for the treatment of Type 2 diabetes mellitus, including short-acting agents like exenatide and lixisenatide, as well as long-acting injectable agents such as albiglutide, dulaglutide, liraglutide, and semaglutide. GLP-1s regulate lipid metabolism, reducing the effects of hyperlipidemia and helping to lower the risk for both chronic kidney disease (CKD) and diabetic kidney disease. They have also been shown to reduce oxidative stress, which includes stimulating glomerular filtration and reducing vasoconstriction, slowing the progression of CKD. Limited data from clinical trials have been published on the effects of GLP-1 receptor agonists in individuals with post-liver transplant diabetes mellitus (PTDM)
Patients often take B12 shots to improve their mood and energy levels, since B12 supports the production of serotonin and dopamine and encourages the conversion of food to energy
Therefore, xanthine oxidase inhibitors reduce UA production from both endogenous and dietary purine sources, making them the first-line therapies for managing hyperuricemia
Questions that were rare even five years ago now surface at nearly every follow-up visit especially among patients who continue to struggle with inflammation, persistent bloating, metabolic syndrome , or weight-related hormonal changes , and in those who feel under-treated or unresponsive to standard medical therapy